Direct analysis of tumor-associated peptide antigens

Chen, 1992, MHC-restricted Responses of CD8+ and CD4+ T-cell Clones from Regional Lymph Nodes of Melanoma Patients, Int J Cancer, 51, 218, 10.1002/ijc.2910510209 Hom, 1991, Common Expression of Melanoma Tumor-associated Antigens Recognized by Human Tumor Infiltrating Lymphocytes: Anal ysis by Human Lymphocyte Antigen Restriction, J Immunother, 10, 153 Gross, 1943, Intradermal Immunization of C3H Mice Against a Sarcoma that Originated in an Animal of the Same Line, Cancer Res, 3, 326 Shu, 1986, In Vitro Sensitization and Expansion with Viable Tumor Cells and Interleukin 2 in the Generation of Specific Therapeutic Effector Cells, J Immunol, 136, 3891, 10.4049/jimmunol.136.10.3891 Rosenberg, 1988, Use of Tumor-infiltrating Lymphocytes and Interleukin 2 in the Immunotherapy of Patients with Metastatic Melanoma, Eew Eng J Med, 319, 1676, 10.1056/NEJM198812223192527 Berd, 1990, Treatment of Metastatic Melanoma with an Autologous Tumor-cell Vaccine: Clinical and Immunologic Results in 64 Patients, J Clin Onc, 8, 1858, 10.1200/JCO.1990.8.11.1858 Mitchell, 1993, Active-specific Immunotherapy of Melanoma with Allogeneic Cell Lysates. Rationale, Results, and Possible Mechanisms of Action, Ann N Y Acad Sci, 690, 153, 10.1111/j.1749-6632.1993.tb44005.x Kawakami, 1994, Identification of a Human Melanoma Antigen Recognized by Tumor Infiltrating Lymphocytes Associated with In Vvo Tumor Rejection Blieden, 1991, Mechanism of Cytolytic T-lymphocyte Killing of a Low Class I-expressing Tumor, J Immunol, 147, 1433, 10.4049/jimmunol.147.4.1433 D'Alessandro, 1987, Immunohistological Evaluation of MHC Class 1 and II Antigen Expression on Nevi and Melanoma: Relation to Biology of Melanoma, Pathology, 19, 339, 10.3109/00313028709103880 Levitsky, 1994, In Vivo Priming of Two Distinct Anti-tumor Effector Populations: the Role of MHC Class I Expression, J Exp Med, 179, 1215, 10.1084/jem.179.4.1215 Vegh, 1993, Selectively Down-regulated Expression of Major Histocompatibility Complex Class I Alleles in Human Solid Tumors, Cancer Res, 53, 2416 Altomonte, 1993, Differential Expression of Cell Adhesion Molecules CD54/CD11a and CD58/CD2 by Human Melanoma Cells and Functional Role in Their Interaction with Cytotoxic Cells, Cancer Res, 53, 3343 Ramarathinam, 1994, T Cell Co-stimulation by B7/BB1 Induces CD8 T Cell-dependent Tumor Rejection: an Important Role of B7/BB1 in the Induction, Recruitment and Effector Function of Anti-tumor T Cells, J Exp Mod, 179, 1205, 10.1084/jem.179.4.1205 Knuth, 1989, Cytolytic T-cell Clones Against an Autologous Human Melanoma: Specificity Study and Definition of Three Antigens by Immunoselection, 86, 2804 Seung, 1993, A Tumor Escape Variant that has Lost One Major Histocompatibility Complex Class I Restriction Element Induces Specific CD8 T Cells to an Antigen that no Longer Serves as a Target, J Exp Med, 178, 933, 10.1084/jem.178.3.933 Restifo, 1983, Identification of Human Cancers Deficient in Antigen Processing, J Exp Med, 177, 265, 10.1084/jem.177.2.265 Townsend, 1989, Antigen Recognition by Class I-restricted T Lymphocytes, Annu Rev Immunol, 7, 601, 10.1146/annurev.iy.07.040189.003125 Boon, 1994, Tumor Antigens Recognized by T Lymphocytes, Annu Rev Immunol, 12, 337, 10.1146/annurev.iy.12.040194.002005 Pardoll, 1994, Tumour Antigens: a New Look for the 1990s, Nature, 369, 357, 10.1038/369357a0 Engelhard, 1994, Structure of Peptides Associated with MHC Class I Molecules, Curr Opin Immunol, 6, 13, 10.1016/0952-7915(94)90028-0 Masucci, 1993, Viral Immunopathology of Human Tumors, Curr Opin Immunol, 5, 693, 10.1016/0952-7915(93)90123-A Banks, 1993, Recognition by and in Vitro induction of Cytotoxic T Lymphocytes Against Predicted Epitopes of the Immediate-early Protein ICP27 of Herpes Simplex Virus, J. Virol, 67, 613, 10.1128/JVI.67.1.613-616.1993 Nayersina, 1993, HLA-A2 Restricted Cytotoxic T Lymphocyte Responses to Multiple Hepatitis B Surface Antigen Epitopes During Hepatitis B Virus Infections, J Immunol, 150, 4659, 10.4049/jimmunol.150.10.4659 Khanna, 1993, EBV Peptide Epitope Sensitization Restores Human Cytotoxic T-cell Recognition of Burkitt's Lymphoma Cells - Evidence for a Critical Role for ICAM-2, J Immunol, 150, 5154, 10.4049/jimmunol.150.11.5154 Feltkamp, 1993, Vaccination with Cytotoxic T-lymphocyte Epitope-containing Peptide Protects Against a Tumor Induced by Human Pa pillomavirus Type 16-transformed Cell, Eur J Immunol, 23, 2242, 10.1002/eji.1830230929 Traversari, 1992, Transfection and Expression of a Gene Coding for a Human Melanoma Antigen Recognized by Autologous Cytolytic T Lymphocytes, Immunogenetics, 35, 145, 10.1007/BF00185107 Tsomides, 1991, An Optimal Viral Peptide Recognized by CD8+ T Cells Binds Very Tightly to the Restricting Class I Major Histocompatibility Complex Protein on Intact Cells but not to the Purified Class I Protein, 88, 11276 Henderson, 1993, Direct Identification of an Endogenous Peptide Recognized by Multiple HLA-A2.1-specific Cytotoxic T Cells, 90, 10275 Cox, 1994, Identification of a Peptide Recognized by Five Melanoma-specific Human Cytotoxic T-cell Lines, Science, 264, 716, 10.1126/science.7513441 Mandelboim, 1994, The Tumor-associated Antigen of a Murine Lung Carcinoma: CTL Induction by an Endogenous Octapeptide(s), Nature, 369, 67, 10.1038/369067a0 Traversari, 1992, A Nonapeptide Encoded by Human Gene MAGE-1 is Recognized on HLA-Al by Cytolytic T lymphocytes Directed Against Tumor Antigen MZ2-E, J Exp Med, 176, 1453, 10.1084/jem.176.5.1453 van der Bruggen, 1994, Autologous Cytolytic T Lymphocytes Recognize a MAGE-1 Nonapeptide on Melanomas Expressing HLACw1601, Eur J Immunol Zakut, 1993, Differential Expression of MAGE-1, -2 and - 3 Messenger RNA in Transformed and Normal Human Cell Lines, Cancer Res, 53, 5 van der Bruggen, 1991, A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma, Science, 254, 1643, 10.1126/science.1840703 Gaugler, 1994, Human Gene MAGE-3 Codes for an Antigen Recognized on a Melanoma by Autologous Cytolytic T Lymphocytes, J Exp Med, 179, 921, 10.1084/jem.179.3.921 Celis, 1994, Induction of Anti-tumor Cytotoxic T Lymphocytes in Normal Humans Using Primary Cultures and Synthetic Peptide Epitopes, 91, 2105 Brichard, 1993, The Tyrosinase Gene Codes for an Antigen Recognized by Autologous Cytolytic T lymphocytes on HLAA2 Melanomas, J Exp Med, 178, 489, 10.1084/jem.178.2.489 Wolfel, 1994, Two Tyrosinase Nonapeptides Recognized on HLA-A2 Melanomas by Autologous Cytolytic T Lymphocytes, Eur J Immunol, 24, 759, 10.1002/eji.1830240340 Robbins, 1994, Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy, Cancer Res, 54, 3124 Topalian, 1994, Human CD4 T Cells Specifically Recognize a Shared Melanoma-Associated Antigen Encoded by the Tyrosinase Gene, 10.1073/pnas.91.20.9461 Bakker, 1994, Melanoma Lineage-Specific Antigen gp100 is Recognized by Melanoma-Derived Tumor-Infiltrating Lymphocytes, J Exp Med, 179, 1005, 10.1084/jem.179.3.1005 Smoller, 1991, HMB-45 Monoclonal Antibody Recognizes an Inducible and Reversible Melanocyte Cytoplasmic Protein, J Cut Pathol, 18, 315, 10.1111/j.1600-0560.1991.tb01542.x Colombari, 1988, Distribution of Melanoma-specific Antibody (HMB-45) in Benign and Malignant Melanocytic Tumours. An immunohistochemical Study on Paraffin Sections, Virchows Archiv [A], 413, 17, 10.1007/BF00844277 Adema, 1993, elanocyte Lineage-specific Antigens Recognized by Monoclonal Antibodies NKI-beteb, HMB- 50, HMB-45 are Encoded by a Single cDNA, Am J Pathol, 143, 1579 Vennegoor, 1988, A Monoclonal Antibody Specific for Cells of the Melanocyte Lineage, Am J Pathol, 130, 179 Kawakami, 1994, Identification of the Immunodominant Peptides of the MART-1 Human Melanoma Antigen Recognized by the Majority of HLA-A2 Restricted Tumor Infiltrating Lymphocytes, J Exp Med, 180, 347, 10.1084/jem.180.1.347 Kwon, 1987, A Melanocyte-specific Complementary DNA Clone Whose Expression is Inducible by Melanotropin and Isobutylmethyl Xanthine, Mol Biol Med, 4, 339 Kwon, 1991, A Melanocyte-specific Gene, Pmel 17, Maps Near the Silver Coat Color Locus on Mouse Chromosome 10 and is in a Syntenic Region on Human Chromosome 12, 88, 9228 Kawakami, 1994, Cloning of the Gene Coding for a Shared Human Melanoma Antigen Recognized by Autologous T Cells Infiltrating Into Tumor, 91, 3515 Coulie, 1994, A New Gene Encoding for a Differentiation Antigen Recognized by Autologous Cytolytic T Lymphocytes on HLA-A2 Melanomas, J Exp Med, 180, 35, 10.1084/jem.180.1.35 Bystryn, 1987, Prognostic Significance of Hypopigmentation in Malignant Melanoma, Arch Dermatol, 123, 1053, 10.1001/archderm.123.8.1053 Nordlund, 1983, Vitiligo in Patients with Metastatic Melanoma: a Good Prognostic Sign, J Am Acad Dermatol, 9, 689, 10.1016/S0190-9622(83)70182-9 Anichini, 1993, Melanoma Cells and Normal Melanocytes Share Antigens Recognized by HLA-A2-restricted Cytotoxic T Cell Clones from Melanoma Patients, J Exp Med, 177, 989, 10.1084/jem.177.4.989 Boon, 1994, Genes Encoding Tumor Rejection Antigens Schwartz, 1989, Acquisition of immunology Self-tolerance, Cell, 57, 1073, 10.1016/0092-8674(89)90044-5 Wolfel, 1989, Lysis of Human Melanoma Cells by Autologous Cytolytic T Cell Clones. Identification of Human Histocompatibility Leukocyte Antigen A2 as Restriction Element for Three Different Antigens, J Exp Med, 170, 797, 10.1084/jem.170.3.797 Darrow, 1989, The Role of HLA Class I Antigens in Recognition of Melanoma Cells by Tumor-specific Cytotoxic T Lymphocytes. Evidence for Shared Tumor Antigens, J Immunol, 142, 3329, 10.4049/jimmunol.142.9.3329 Slovin, 1986, Cellular Immune Response to Human Sarcomas: Cytotoxic T Cell Clones Reactive with Autologous Sarcomas. I. Development, Phenotypes and Specificity, J Immunol, 137, 3042, 10.4049/jimmunol.137.9.3042 Schendel, 1993, Tumor-specific Lysis of Human Renal Cell Carcinomas by Tumor-infiltrating Lymphocytes. I. HLA-A2-restricted Recognition of Autologous and Allogeneic Tumor Lines, J Immunol, 151, 4209, 10.4049/jimmunol.151.8.4209 Ioannides, 1993, Cytotoxic T-cell Clones Isolated from Ovarian Tumor-infiltrating Lymphocytes Recognize Common Determinants on Non-ovarian Tumour Clones, Scand J Immunol, 37, 413, 10.1111/j.1365-3083.1993.tb03312.x Slingluff, 1994, The Cytotoxic T-lymphocyte Response to Autologous Squamous Cell Cancer of the Lung: Epitope Reconstitution with Peptides Extracted from HLA-Aw68, Cancer Res, 54, 2731 Yasumura, 1993, Human Cytotoxic T-cell Lines with Restricted Specificity for Squamous Cell Carcinoma of the Head and Neck, Cancer Res, 53, 1461 Yasumura, 1994, HLA Restriction and T Cell-receptor V-β Gene Expression of Cytotoxic T Lymphocytes Reactive with Human Squamous-cell Carcinoma of the Head and Neck, Int J Cancer, 57, 297, 10.1002/ijc.2910570302 Ioannides, 1991, Cytotoxic T Cell Clones Isolated from Ovarian Tumorinfiltrating Lymphocytes Recognize Multiple Antigenic Epitopes on Autologous Tumor Cells, J Immunol, 146, 1700, 10.4049/jimmunol.146.5.1700 Peoples, 1993, T-cell Recognition of Ovarian Cancer, Surgery, 114, 227 Peoples, 1993, HLA-A2 Presents Shared Tumorassociated Antigens Derived from Endogenous Proteins in Ovarian Cancer, J Immunol, 151, 5481, 10.4049/jimmunol.151.10.5481 Schwartzentruber, 1992, Characterization of Lymphocytes Infiltrating Human Breast Cancer: Specific Immune Reactivity Detected by Measuring Cytokine Secretion, J Immunother, 12, 1, 10.1097/00002371-199207000-00001 Wolfel, 1993, Lysis of Human Pancreatic Adenocarcinoma Cells by Autologous HLA-class I-restricted Cytolytic T-lymphocyte Cytolytic T-lymphocyte (CTL) Clones, Int I Cancer, 54, 636, 10.1002/ijc.2910540419 Jerome, 1991, Cytotoxic T-lymphocytes Derived from Patients with Breast Adenocarcinoma Recognize an Epitope Present on the Protein Core of a Mucin Molecule Preferentially Expressed by Malignant Cells, Cancer Res, 5, 2908 Ioannides, 1993, Cytotoxic T Cells from Ovarian Malignant Tumors can Recognize Polymorphic Epithelial Mucin Core Peptides, J Immunol, 151, 3693, 10.4049/jimmunol.151.7.3693 Ioannides, 1993, Cytotoxic T Cells Isolated From Ovarian Malignant Ascites Recognize a Peptide Derived from the HER-2/neu proto- oncogene, Cellular Immunology, 151, 225, 10.1006/cimm.1993.1233 Yoshino, 1994, The Sensitivity of Human Ovarian Epithelial Tumor Cells to Cytotoxic T Cells is Associated with the Expression of HER2/neu, J Immunol, 152, 2393, 10.4049/jimmunol.152.5.2393 Houbiers, 1993, In Vitro Induction of Human Cytotoxic T Lymphocyte Responses Against Peptides of Mutant and Wild-type p53, Eur I Immunol, 23, 2072, 10.1002/eji.1830230905 Yanuck, 1993, A Mutant p53 Tumor Suppressor Protein is a Target for Peptide-induced CD8+ Cytotoxic T Cells, Cancer Res, 53, 3257 Fossum, 1994, p21-ras-peptide-specific T-cell Responses in a Patient with Colorectal Cancer. CD4+ and CD8+ T Cells Recognize a Peptide Corresponding to a Common Mutation (13GIy > Asp), Int I Cancer, 56, 40, 10.1002/ijc.2910560108 Skipper, 1993, Identification of Two Cytotoxic T lymphocyte-recognized Epitopes in the ras Protein, J Exp Med, 177, 1493, 10.1084/jem.177.5.1493 Kast, 1993, Human Leukocyte Antigen-A2.1 Restricted Candidate Cytotoxic T Lymphocyte Epitopes of Human Papillomavirus Type 16 E6 and E7 Proteins Identified by Using the Processing-defective Human Cell Line T2, J Immunother, 14, 115, 10.1097/00002371-199308000-00006 Kannagi, 1992, Target Epitope on the Tax Protein of Human T cell-leukemia Virus Type I Recognized by Class I MHC Restricted Cytotoxic T Cells, J Virol, 66, 2928, 10.1128/JVI.66.5.2928-2933.1992 Kannagi, 1993, Expression of the Target Antigen for Cytotoxic T Lymphocytes on Adult T-cell Leukemia Cells, Int I Cancer, 54, 582, 10.1002/ijc.2910540411